Adial Pharmaceuticals (ADIL) Income Statement (2017 - 2026)
Income Statement report data from Jun 30, 2017 to Mar 31, 2026 for Adial Pharmaceuticals (ADIL).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Sep 30, 2017 | Jun 30, 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Expenses | |||||||||||||||||||||||||||||||||
Research And Development | 430K (-30.65%) | 620K (+19.23%) | 520K (-28.77%) | 730K (-2.67%) | 750K (+2.74%) | 730K (-29.13%) | 1.03M (+1.98%) | 1.01M (+124.44%) | 450K (+114.29%) | 210K (-51.16%) | 430K (-36.76%) | 680K (-2.86%) | 700K (-41.67%) | 1.20M (+100.00%) | 600K (-74.25%) | 2.33M (+37.87%) | 1.69M (-27.16%) | 2.32M (+13.17%) | 2.05M (-0.49%) | 2.06M (+11.35%) | 1.85M (+107.87%) | 890K (-16.04%) | 1.06M (-11.67%) | 1.20M (+39.53%) | 860K (-28.93%) | 1.21M (+75.36%) | 690K (+1280.00%) | 50K (-73.68%) | 190K (+137.50%) | 80K (+33.33%) | 60K (+100.00%) | 30K (-50.00%) | 60K |
Selling General And Administrative | 1.57M (+23.62%) | 1.27M (+2.42%) | 1.24M (+7.83%) | 1.15M (-24.34%) | 1.52M (+25.62%) | 1.21M (+2.54%) | 1.18M (-7.09%) | 1.27M (-8.63%) | 1.39M (+20.87%) | 1.15M (+9.52%) | 1.05M (-53.13%) | 2.24M (+20.43%) | 1.86M (-27.34%) | 2.56M (+4.07%) | 2.46M (+17.14%) | 2.10M (-11.39%) | 2.37M (+13.94%) | 2.08M (-25.45%) | 2.79M (+97.87%) | 1.41M (-5.37%) | 1.49M (+60.22%) | 930K (-25.00%) | 1.24M (+39.33%) | 890K (+1.14%) | 880K (-7.37%) | 950K (-39.10%) | 1.56M (+50.00%) | 1.04M (-71.35%) | 3.63M (+118.67%) | 1.66M (+492.86%) | 280K (+75.00%) | 160K (0.00%) | 160K |
Operating Expenses | 2.00M (+5.82%) | 1.89M (+7.39%) | 1.76M (-6.38%) | 1.88M (-17.18%) | 2.27M (+17.01%) | 1.94M (-12.22%) | 2.21M (-3.49%) | 2.29M (+23.78%) | 1.85M (+36.03%) | 1.36M (-8.11%) | 1.48M (-49.32%) | 2.92M (+14.51%) | 2.55M (-33.42%) | 3.83M (+25.16%) | 3.06M (-48.83%) | 5.98M (+47.29%) | 4.06M (-7.73%) | 4.40M (-9.09%) | 4.84M (+39.48%) | 3.47M (+3.89%) | 3.34M (+83.52%) | 1.82M (-20.87%) | 2.30M (+10.05%) | 2.09M (+19.43%) | 1.75M (-18.98%) | 2.16M (-4.00%) | 2.25M (+106.42%) | 1.09M (-71.47%) | 3.82M (+119.54%) | 1.74M (+411.76%) | 340K (+30.77%) | 260K (+8.33%) | 240K |
Operating Income | |||||||||||||||||||||||||||||||||
Operating Income | -2.00M (+5.82%) | -1.89M (+7.39%) | -1.76M (-6.38%) | -1.88M (-17.18%) | -2.27M (+17.01%) | -1.94M (-12.22%) | -2.21M (-3.49%) | -2.29M (+23.78%) | -1.85M (+36.03%) | -1.36M (-8.11%) | -1.48M (-49.32%) | -2.92M (+14.51%) | -2.55M (-33.42%) | -3.83M (+25.16%) | -3.06M (-48.83%) | -5.98M (+47.29%) | -4.06M (-7.73%) | -4.40M (-9.09%) | -4.84M (+39.48%) | -3.47M (+3.89%) | -3.34M (+83.52%) | -1.82M (-20.87%) | -2.30M (+10.05%) | -2.09M (+19.43%) | -1.75M (-18.98%) | -2.16M (-4.00%) | -2.25M (+106.42%) | -1.09M (-71.47%) | -3.82M (+119.54%) | -1.74M (+411.76%) | -340.00K (+30.77%) | -260.00K (+8.33%) | -240.00K |
Ebit | -2.00M (+5.82%) | -1.89M (+7.39%) | -1.76M (-6.38%) | -1.88M (-17.18%) | -2.27M (+17.01%) | -1.94M (-12.22%) | -2.21M (-3.49%) | -2.29M (+23.78%) | -1.85M (+36.03%) | -1.36M (-8.11%) | -1.48M (-49.32%) | -2.92M (+14.51%) | -2.55M (-33.42%) | -3.83M (+25.16%) | -3.06M (-48.83%) | -5.98M (+47.29%) | -4.06M (-7.73%) | -4.40M (-9.09%) | -4.84M (+39.48%) | -3.47M (+3.89%) | -3.34M (+83.52%) | -1.82M (-20.87%) | -2.30M (+10.05%) | -2.09M (+19.43%) | -1.75M (-18.98%) | -2.16M (-4.00%) | -2.25M (+106.42%) | -1.09M (-71.47%) | -3.82M (+119.54%) | -1.74M (+411.76%) | -340.00K (+30.77%) | -260.00K (+8.33%) | -240.00K |
EBITDA | -2.02M (+1.00%) | -2.00M (+11.73%) | -1.79M (-8.67%) | -1.96M (-12.11%) | -2.23M (+7.73%) | -2.07M (-5.48%) | -2.19M (-10.98%) | -2.46M (-62.04%) | -6.48M (+369.57%) | -1.38M | 1.09M | -2.91M (-6.43%) | -3.11M (-19.22%) | -3.85M (+32.30%) | -2.91M (-50.84%) | -5.92M (+37.04%) | -4.32M (-2.70%) | -4.44M (-8.07%) | -4.83M (+39.19%) | -3.47M (+3.89%) | -3.34M (+84.53%) | -1.81M (-20.61%) | -2.28M (+10.68%) | -2.06M (+19.77%) | -1.72M (-19.25%) | -2.13M (-20.52%) | -2.68M (+103.03%) | -1.32M (-83.88%) | -8.19M (+370.69%) | -1.74M (+357.89%) | -380.00K (+31.03%) | -290.00K (+20.83%) | -240.00K |
Other Income / Expenses | |||||||||||||||||||||||||||||||||
Interest Income | 50K (+25.00%) | 40K (-20.00%) | 50K (+150.00%) | 20K (-50.00%) | 40K (-20.00%) | 50K (0.00%) | 50K (0.00%) | 50K (+150.00%) | 20K (+100.00%) | 10K (-50.00%) | 20K | - | - | 10K | - | - | - | - | - | - | - | 10K (-50.00%) | 20K (-33.33%) | 30K (0.00%) | 30K (+50.00%) | 20K (+100.00%) | 10K (0.00%) | 10K | - | - | - | - | - |
Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -50.00K | - | 50K | - | - | 20K |
Net Interest Income | 50K (+25.00%) | 40K (-20.00%) | 50K (+150.00%) | 20K (-50.00%) | 40K (-20.00%) | 50K (0.00%) | 50K (0.00%) | 50K (+150.00%) | 20K (+100.00%) | 10K (-50.00%) | 20K | - | - | 10K | - | - | - | - | - | - | - | 10K (-50.00%) | 20K (-33.33%) | 30K (0.00%) | 30K (+50.00%) | 20K (+100.00%) | 10K (-83.33%) | 60K | - | -50.00K | - | - | -20.00K |
Other Non Operating Income | -20.00K | 160K | - | - | 170K | -80.00K | 20K | -170.00K | - | 10K | -30.00K | 10K | - | -20.00K | 150K | -230.00K (-8.00%) | -250.00K (+525.00%) | -40.00K | 10K (-66.67%) | 30K | - | 10K (-50.00%) | 20K | -350.00K | 30K (+50.00%) | 20K | -430.00K (-90.73%) | -4.64M (+6.18%) | -4.37M (+8640.00%) | -50.00K (+25.00%) | -40.00K (+33.33%) | -30.00K (+50.00%) | -20.00K |
Net Income | |||||||||||||||||||||||||||||||||
Income Before Tax | - | -7.98M | - | - | - | -8.55M (+290.41%) | -2.19M (-10.98%) | -2.46M | - | -1.35M (-10.60%) | -1.51M (-48.11%) | -2.91M (+14.12%) | -2.55M (-33.77%) | -3.85M (+32.30%) | -2.91M (-50.84%) | -5.92M (+37.04%) | -4.32M (-2.70%) | -4.44M (-8.07%) | -4.83M (+39.19%) | -3.47M (+3.89%) | -3.34M (+84.53%) | -1.81M (-20.61%) | -2.28M (+10.68%) | -2.06M (+19.77%) | -1.72M (-19.25%) | -2.13M (-20.52%) | -2.68M (+111.02%) | -1.27M (-84.49%) | -8.19M (+357.54%) | -1.79M (+371.05%) | -380.00K (+31.03%) | -290.00K (+11.54%) | -260.00K |
Income Tax Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -90.00K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income From Continuing Operations | -2.02M (+1.00%) | -2.00M (+11.73%) | -1.79M (-8.67%) | -1.96M (-12.11%) | -2.23M (+7.73%) | -2.07M (-5.48%) | -2.19M (-10.98%) | -2.46M (-62.04%) | -6.48M (+369.57%) | -1.38M | 1.09M | -2.91M (-6.43%) | -3.11M (-19.22%) | -3.85M (+32.30%) | -2.91M (-50.09%) | -5.83M (+34.95%) | -4.32M (-2.70%) | -4.44M (-8.07%) | -4.83M (+39.19%) | -3.47M (+3.89%) | -3.34M (+84.53%) | -1.81M (-20.61%) | -2.28M (+10.68%) | -2.06M (+19.77%) | -1.72M (-19.25%) | -2.13M (-20.52%) | -2.68M (+111.02%) | -1.27M (-84.49%) | -8.19M (+357.54%) | -1.79M (+371.05%) | -380.00K (+31.03%) | -290.00K (+11.54%) | -260.00K |
Net Income | -2.02M (+1.00%) | -2.00M (+11.73%) | -1.79M (-8.67%) | -1.96M (-12.11%) | -2.23M (+7.73%) | -2.07M (-5.48%) | -2.19M (-10.98%) | -2.46M (-62.04%) | -6.48M (+369.57%) | -1.38M | 1.09M | -2.91M (-6.43%) | -3.11M (-19.22%) | -3.85M (+32.30%) | -2.91M (-50.09%) | -5.83M (+34.95%) | -4.32M (-2.70%) | -4.44M (-8.07%) | -4.83M (+39.19%) | -3.47M (+3.89%) | -3.34M (+84.53%) | -1.81M (-20.61%) | -2.28M (+10.68%) | -2.06M (+19.77%) | -1.72M (-19.25%) | -2.13M (-20.52%) | -2.68M (+111.02%) | -1.27M (-84.49%) | -8.19M (+357.54%) | -1.79M (+371.05%) | -380.00K (+31.03%) | -290.00K (+11.54%) | -260.00K |